Ticker
SABSCompany Name
SAB BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -30.77M | -26829.57% | $ 114.7K |
3/31/2025 | $ -31.34M | -8294.42% | $ 377.83K |
12/31/2024 | $ -34.29M | -2593.15% | $ 1.32M |
9/30/2024 | $ -38.21M | -2525.68% | $ 1.51M |
6/30/2024 | $ -37.08M | -1333.86% | $ 2.78M |
3/31/2024 | $ -34.26M | -1316.59% | $ 2.6M |
12/31/2023 | $ -25.12M | -1121.91% | $ 2.24M |
9/30/2023 | $ -11.46M | -279.77% | $ 4.09M |
6/30/2023 | $ -14.46M | -225.36% | $ 6.42M |
3/31/2023 | $ -14.77M | -116.48% | $ 12.68M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for SAB BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ 3.76M ] / Revenues [ $ 60.88M ]
(=) OCF % [ 6.17% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |